These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21085654)

  • 1. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.
    Ling KK; Lin MY; Zingg B; Feng Z; Ko CP
    PLoS One; 2010 Nov; 5(11):e15457. PubMed ID: 21085654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of VGLUT1 synapses on ventral calbindin-immunoreactive interneurons and normal locomotor function in a mouse model of spinal muscular atrophy.
    Thirumalai V; Behrend RM; Birineni S; Liu W; Blivis D; O'Donovan MJ
    J Neurophysiol; 2013 Feb; 109(3):702-10. PubMed ID: 23136344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.
    Kong L; Wang X; Choe DW; Polley M; Burnett BG; Bosch-Marcé M; Griffin JW; Rich MM; Sumner CJ
    J Neurosci; 2009 Jan; 29(3):842-51. PubMed ID: 19158308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
    Mole AJ; Bell S; Thomson AK; Dissanayake KN; Ribchester RR; Murray LM
    J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.
    Udina E; Putman CT; Harris LR; Tyreman N; Cook VE; Gordon T
    J Physiol; 2017 Mar; 595(5):1815-1829. PubMed ID: 27891608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.
    Ackermann B; Kröber S; Torres-Benito L; Borgmann A; Peters M; Hosseini Barkooie SM; Tejero R; Jakubik M; Schreml J; Milbradt J; Wunderlich TF; Riessland M; Tabares L; Wirth B
    Hum Mol Genet; 2013 Apr; 22(7):1328-47. PubMed ID: 23263861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.
    Mentis GZ; Blivis D; Liu W; Drobac E; Crowder ME; Kong L; Alvarez FJ; Sumner CJ; O'Donovan MJ
    Neuron; 2011 Feb; 69(3):453-67. PubMed ID: 21315257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy.
    Ling KK; Gibbs RM; Feng Z; Ko CP
    Hum Mol Genet; 2012 Jan; 21(1):185-95. PubMed ID: 21968514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice.
    Neve A; Trüb J; Saxena S; Schümperli D
    Mol Cell Neurosci; 2016 Jan; 70():30-41. PubMed ID: 26621405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM; Blanco-Redondo B; Buettner JM; Pagiazitis JG; Fletcher EV; Sime Longang JK; Mentis GZ
    J Neurosci; 2021 Jan; 41(2):376-389. PubMed ID: 33219005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
    Kariya S; Park GH; Maeno-Hikichi Y; Leykekhman O; Lutz C; Arkovitz MS; Landmesser LT; Monani UR
    Hum Mol Genet; 2008 Aug; 17(16):2552-69. PubMed ID: 18492800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK; Caine C; Awano T; Herbst R; Monani UR
    Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.
    Tejero R; Lopez-Manzaneda M; Arumugam S; Tabares L
    Hum Mol Genet; 2016 Nov; 25(21):4703-4716. PubMed ID: 28173138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy.
    Tarabal O; Caraballo-Miralles V; Cardona-Rossinyol A; Correa FJ; Olmos G; Lladó J; Esquerda JE; Calderó J
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):519-35. PubMed ID: 24806302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.
    Lee YI; Mikesh M; Smith I; Rimer M; Thompson W
    Dev Biol; 2011 Aug; 356(2):432-44. PubMed ID: 21658376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM; Beauvais A; Bhanot K; Kothary R
    Neurobiol Dis; 2013 Jan; 49():57-67. PubMed ID: 22960106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.